AML 60-80 years: Who should get an allo transplant?

imedex has 1334 videos Subscribe Here

Description: Earn CME:

In this presentation from the 'FLT3 Targets in RIn this presentation from the 'R AML: Evaluating Emerging Clinical Data and Implications on Current Practice’ symposium, Dr. Koen van Besien discusses whether acute myeloid leuekemia patients between the ages of 60 and 80 should receive an allogeneic stem cell transplant.

© 2018 Imedex, an HMP Company
Shared By : imedex
Posted on : 11/28/18
Added : 9 months ago